Clinical Impact of Nutrition and Inflammation Assessment Tools in Pancreatic Cancer Treatment

被引：19
作者：
Aoyama, Toru [1 ,2 ]
Maezawa, Yukio [1 ,2 ]
Hashimoto, Itaru [1 ,2 ]
Rino, Yasushi [1 ]
Oshima, Takashi [1 ,2 ]
机构：
[1] Yokohama City Univ, Dept Surg, 3-9 Fukuura,Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan
[2] Kanagawa Canc Ctr, Dept Gastrointestinal Surg, Yokohama, Kanagawa, Japan
来源：
ANTICANCER RESEARCH | 2023年 / 43卷 / 09期
关键词：
Nutritional assessment; inflammation assessment; pancreatic cancer; review; TO-LYMPHOCYTE RATIO; CARBOHYDRATE ANTIGEN 19-9; GLASGOW PROGNOSTIC SCORE; DUCTAL ADENOCARCINOMA; PREDICTS SURVIVAL; INDEX PREDICTS; NEUTROPHIL; CHEMOTHERAPY; GEMCITABINE; CA19-9;
D O I：
10.21873/anticanres.16572
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Perioperative adjuvant treatment and complete resection is the standard treatment for resectable pancreatic cancer and systemic chemotherapy is standard treatment for unresectable pancreatic cancer. To improve the survival of patients with pancreatic cancer, it is necessary to identify promising biomarkers to optimize the treatment. The availability of biomarkers may allow patients to receive a more aggressive or less toxic treatment. Recent studies showed that the inflammatory and nutritional status perioperatively and/or during chemotherapy affect short and long-term oncological outcomes in pancreatic cancer. Introduction of inflammatory and nutritional status evaluation in pancreatic cancer treatment might improve the postoperative surgical complications or chemotherapy-induced adverse events. However, to introduce these various nutritional and inflammation assessment tools in daily clinical practice, it is necessary to understand the characteristics of each nutrition and inflammation assessment tool. This review summarizes the background, current status, and future perspectives of nutrition and inflammation assessment tools in pancreatic cancer treatment.
引用
收藏
页码：3849 / 3860
页数：12
相关论文
共 104 条
[1]   Preoperative neutrophil-to-lymphocyte ratio as a prognosticator in early stage pancreatic ductal adenocarcinoma [J].
Abe, Tomoyuki ;
Amano, Hironobu ;
Kobayashi, Tsuyoshi ;
Hanada, Keiji ;
Nakahara, Masahiro ;
Ohdan, Hideki ;
Noriyuki, Toshio .
EJSO, 2018, 44 (10) :1573-1579
[2]   Elevated neutrophil to lymphocyte ratio predicts survival in advanced pancreatic cancer [J].
An, Xin ;
Ding, Pei-Rong ;
Li, Yu-Hong ;
Wang, Feng-Hua ;
Shi, Yan-Xia ;
Wang, Zhi-Qiang ;
He, You-Jian ;
Xu, Rui-Hua ;
Jiang, Wen-Qi .
BIOMARKERS, 2010, 15 (06) :516-522
[3]   Usefulness of Nutrition and Inflammation Assessment Tools in Esophageal Cancer Treatment [J].
Aoyama, Toru ;
Kazama, Keisuke ;
Maezawa, Yukio ;
Hara, Kentaro .
IN VIVO, 2023, 37 (01) :22-35
[4]   Clinical Impact of Nutrition and Inflammation Assessment Tools in Gastric Cancer Treatment [J].
Aoyama, Toru ;
Hara, Kentaro ;
Kazama, Keisuke ;
Maezawa, Yukio .
ANTICANCER RESEARCH, 2022, 42 (11) :5167-5180
[5]   Prognostic impact of preoperative NLR and CA19-9 in pancreatic cancer [J].
Asaoka, Tadafumi ;
Miyamoto, Atsushi ;
Maeda, Sakae ;
Tsujie, Masanori ;
Hama, Naoki ;
Yamamoto, Kazuyoshi ;
Miyake, Masakazu ;
Haraguchi, Naotsugu ;
Nishikawa, Kazuhiro ;
Hirao, Motohiro ;
Ikeda, Masataka ;
Sekimoto, Mitsugu ;
Nakamori, Shoji .
PANCREATOLOGY, 2016, 16 (03) :434-440
[6]   Preoperative hematologic markers as independent predictors of prognosis in resected pancreatic ductal adenocarcinoma: neutrophil-lymphocyte versus platelet-lymphocyte ratio [J].
Bhatti, Imran ;
Peacock, Oliver ;
Lloyd, Gareth ;
Larvin, Michael ;
Hall, Richard I. .
AMERICAN JOURNAL OF SURGERY, 2010, 200 (02) :197-203
[7]  
[Anonymous], 2020, CA Cancer J Clin, V70, P313, DOI [10.3322/caac.21492, 10.3322/caac.21609]
[8]   Prognostic value of the neutrophil-to-lymphocyte ratio and carbohydrate antigen 19-9 in estimating survival in patients with metastatic pancreatic cancer [J].
Cetin, Sirin ;
Dede, Isa .
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2020, 16 (04) :909-916
[9]   Significance of baseline and change in neutrophil-to-lymphocyte ratio in predicting prognosis: a retrospective analysis in advanced pancreatic ductal adenocarcinoma [J].
Chen, Yang ;
Yan, Huan ;
Wang, YanRong ;
Shi, Yan ;
Dai, GuangHai .
SCIENTIFIC REPORTS, 2017, 7
[10]   Competing Risk Analysis of Outcomes of Unresectable Pancreatic Cancer Patients Undergoing Definitive Radiotherapy [J].
Chen, Yi-Lun ;
Tsai, Chiao-Ling ;
Cheng, Jason Chia-Hsien ;
Wang, Chun-Wei ;
Yang, Shih-Hung ;
Tien, Yu-Wen ;
Kuo, Sung-Hsin .
FRONTIERS IN ONCOLOGY, 2022, 11
12345678910